{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T06:36:19Z","timestamp":1772692579137,"version":"3.50.1"},"reference-count":76,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.path.2019.10.001","type":"journal-article","created":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T08:59:51Z","timestamp":1575363591000},"page":"73-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Diagnosis of Mesothelioma"],"prefix":"10.1016","volume":"13","author":[{"given":"Daffolyn Rachael","family":"Fels Elliott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirk D.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.path.2019.10.001_bib1","article-title":"Mesothelium and malignant mesothelioma","volume":"7","author":"Hiriart","year":"2019","journal-title":"J\u00a0Dev Biol"},{"issue":"7","key":"10.1016\/j.path.2019.10.001_bib2","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1080\/10408440903044928","article-title":"Time trend of mesothelioma incidence in the United States and projection of future cases: an update based on SEER data for 1973 through 2005","volume":"39","author":"Price","year":"2009","journal-title":"Crit Rev Toxicol"},{"issue":"18","key":"10.1016\/j.path.2019.10.001_bib3","first-page":"319","article-title":"Malignant pleural mesothelioma: incidence, etiology, diagnosis, treatment, and occupational health","volume":"110","author":"Neumann","year":"2013","journal-title":"Dtsch Arztebl Int"},{"issue":"3","key":"10.1016\/j.path.2019.10.001_bib4","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2486\/indhealth.45.379","article-title":"Malignant mesothelioma: global incidence and relationship with asbestos","volume":"45","author":"Bianchi","year":"2007","journal-title":"Ind Health"},{"issue":"4","key":"10.1016\/j.path.2019.10.001_bib5","first-page":"491","article-title":"Malignant pleural mesothelioma: an epidemiological perspective","volume":"1","author":"Robinson","year":"2012","journal-title":"Ann Cardiothorac Surg"},{"key":"10.1016\/j.path.2019.10.001_bib6","first-page":"260","article-title":"Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape province","volume":"17","author":"Wagner","year":"1960","journal-title":"Br J Ind Med"},{"issue":"6","key":"10.1016\/j.path.2019.10.001_bib7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/ajim.20951","article-title":"Rarity of malignant mesothelioma prior to the widespread commercial introduction of asbestos: the Mount Sinai autopsy experience 1883-1910","volume":"54","author":"Strauchen","year":"2011","journal-title":"Am J Ind Med"},{"issue":"4","key":"10.1016\/j.path.2019.10.001_bib8","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/jim-2017-000628","article-title":"Biological responses to asbestos inhalation and pathogenesis of asbestos-related benign and malignant disease","volume":"66","author":"Solbes","year":"2018","journal-title":"J\u00a0Investig Med"},{"issue":"8","key":"10.1016\/j.path.2019.10.001_bib9","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1200\/JCO.1989.7.8.1157","article-title":"Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients","volume":"7","author":"Ruffie","year":"1989","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.path.2019.10.001_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2486\/indhealth.39.161","article-title":"Asbestos exposure in malignant mesothelioma of the pleura: a survey of 557 cases","volume":"39","author":"Bianchi","year":"2001","journal-title":"Ind Health"},{"issue":"11","key":"10.1016\/j.path.2019.10.001_bib11","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1136\/oemed-2017-104383","article-title":"Non-occupational exposure to asbestos and risk of pleural mesothelioma: review and meta-analysis","volume":"74","author":"Marsh","year":"2017","journal-title":"Occup Environ Med"},{"issue":"1","key":"10.1016\/j.path.2019.10.001_bib12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12940-018-0431-9","article-title":"Association between mesothelioma and non-occupational asbestos exposure: systematic review and meta-analysis","volume":"17","author":"Xu","year":"2018","journal-title":"Environ Health"},{"issue":"4","key":"10.1016\/j.path.2019.10.001_bib13","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1136\/oemed-2016-104119","article-title":"The epidemiology of malignant mesothelioma in women: gender differences and modalities of asbestos exposure","volume":"75","author":"Marinaccio","year":"2018","journal-title":"Occup Environ Med"},{"issue":"1","key":"10.1016\/j.path.2019.10.001_bib14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.5271\/sjweh.3756","article-title":"Non-occupational exposure to asbestos is the main cause of malignant mesothelioma in women in North Jutland, Denmark","volume":"45","author":"Panou","year":"2019","journal-title":"Scand J Work Environ Health"},{"issue":"18","key":"10.1016\/j.path.2019.10.001_bib15","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1016\/j.ejca.2007.09.018","article-title":"Analysis of latency time and its determinants in asbestos related malignant mesothelioma cases of the Italian register","volume":"43","author":"Marinaccio","year":"2007","journal-title":"Eur J Cancer"},{"issue":"7","key":"10.1016\/j.path.2019.10.001_bib16","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1038\/bjc.2013.514","article-title":"The latency period of mesothelioma among a cohort of British asbestos workers (1978-2005)","volume":"109","author":"Frost","year":"2013","journal-title":"Br J Cancer"},{"issue":"11","key":"10.1016\/j.path.2019.10.001_bib17","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/JTO.0b013e31826915f1","article-title":"Initial analysis of the International Association for the Study of Lung Cancer mesothelioma database","volume":"7","author":"Rusch","year":"2012","journal-title":"J\u00a0Thorac Oncol"},{"issue":"10","key":"10.1016\/j.path.2019.10.001_bib18","doi-asserted-by":"crossref","first-page":"716","DOI":"10.2471\/BLT.11.086678","article-title":"Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008","volume":"89","author":"Delgermaa","year":"2011","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.path.2019.10.001_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-3-642-10862-4_2","article-title":"Epidemiology of mesothelioma and historical background","volume":"189","author":"Craighead","year":"2011","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.path.2019.10.001_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-217348","article-title":"Rare presentation of a localised malignant pleural mesothelioma with cranial metastasis","volume":"2016","author":"Ertan","year":"2016","journal-title":"BMJ Case Rep"},{"issue":"5","key":"10.1016\/j.path.2019.10.001_bib21","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1378\/chest.11-3204","article-title":"Postmortem findings of malignant pleural mesothelioma: a two-center study of 318 patients","volume":"142","author":"Finn","year":"2012","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.path.2019.10.001_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/RLU.0000000000002349","article-title":"18F-FDG PET\/CT revealing constrictive pericarditis as the only manifestation of malignant mesothelioma","volume":"44","author":"Edel","year":"2019","journal-title":"Clin Nucl Med"},{"issue":"4","key":"10.1016\/j.path.2019.10.001_bib23","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1177\/1076029614564861","article-title":"Thromboembolic events in malignant pleural mesothelioma","volume":"22","author":"Koksal","year":"2016","journal-title":"Clin Appl Thromb Hemost"},{"issue":"6","key":"10.1016\/j.path.2019.10.001_bib24","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1053\/j.sult.2017.07.006","article-title":"Malignant pleural mesothelioma: diagnosis, staging, pitfalls and follow-up","volume":"38","author":"Odisio","year":"2017","journal-title":"Semin Ultrasound CT MR"},{"issue":"12","key":"10.1016\/j.path.2019.10.001_bib25","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1016\/j.ejrad.2012.08.008","article-title":"Development of a guideline on reading CT images of malignant pleural mesothelioma and selection of the reference CT films","volume":"81","author":"Zhou","year":"2012","journal-title":"Eur J Radiol"},{"issue":"6","key":"10.1016\/j.path.2019.10.001_bib26","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1148\/rg.346130089","article-title":"Multimodality imaging for characterization, classification, and staging of malignant pleural mesothelioma","volume":"34","author":"Nickell","year":"2014","journal-title":"Radiographics"},{"issue":"5","key":"10.1016\/j.path.2019.10.001_bib27","first-page":"326","article-title":"Pleural and parenchymal lung diseases from asbestos exposure. CT diagnosis","volume":"100","author":"Polverosi","year":"2000","journal-title":"Radiol Med"},{"issue":"4","key":"10.1016\/j.path.2019.10.001_bib28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00000478-199404000-00004","article-title":"Localized malignant mesothelioma. A clinicopathologic and flow cytometric study","volume":"18","author":"Crotty","year":"1994","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.path.2019.10.001_bib29","first-page":"18367","article-title":"Massive localized malignant pleural mesothelioma (LMPM): manifestations on computed tomography in 6 cases","volume":"8","author":"Yao","year":"2015","journal-title":"Int J Clin Exp Med"},{"issue":"6","key":"10.1016\/j.path.2019.10.001_bib30","doi-asserted-by":"crossref","first-page":"E379","DOI":"10.21037\/jtd.2016.03.92","article-title":"Localized malignant pleural sarcomatoid mesothelioma misdiagnosed as benign localized fibrous tumor","volume":"8","author":"Kim","year":"2016","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.path.2019.10.001_bib31","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejro.2019.01.006","article-title":"Localized malignant pleural mesothelioma mimicking an anterior mediastinal tumor","volume":"6","author":"Hino","year":"2019","journal-title":"Eur J Radiol Open"},{"issue":"15","key":"10.1016\/j.path.2019.10.001_bib32","doi-asserted-by":"crossref","first-page":"e15147","DOI":"10.1097\/MD.0000000000015147","article-title":"Primary malignant mesothelioma of the diaphragm with liver invasion: a case report and review of literature","volume":"98","author":"Huang","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.path.2019.10.001_bib33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/RMR.0000000000000162","article-title":"MR imaging of pleural neoplasms","volume":"27","author":"Carter","year":"2018","journal-title":"Top Magn Reson Imaging"},{"issue":"1","key":"10.1016\/j.path.2019.10.001_bib34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1148\/rg.2018170091","article-title":"Mediastinal and pleural MR imaging: practical approach for daily practice","volume":"38","author":"Raptis","year":"2018","journal-title":"Radiographics"},{"issue":"1","key":"10.1016\/j.path.2019.10.001_bib35","doi-asserted-by":"crossref","first-page":"e10949","DOI":"10.5812\/iranjradiol.10949","article-title":"Malignant mesothelioma versus metastatic carcinoma of the pleura: a CT challenge","volume":"13","author":"Bakhshayesh Karam","year":"2016","journal-title":"Iran J Radiol"},{"issue":"2","key":"10.1016\/j.path.2019.10.001_bib36","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/MNM.0000000000000789","article-title":"18F-Fluorodeoxyglucose PET\/CT and dynamic contrast-enhanced MRI as imaging biomarkers in malignant pleural mesothelioma","volume":"39","author":"Hall","year":"2018","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.path.2019.10.001_bib37","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.lungcan.2018.11.033","article-title":"Imaging in pleural mesothelioma: a review of the 14th International Conference of the International Mesothelioma Interest Group","volume":"130","author":"Armato","year":"2019","journal-title":"Lung Cancer"},{"issue":"12","key":"10.1016\/j.path.2019.10.001_bib38","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1097\/JTO.0b013e3181c0a7ff","article-title":"Clinical value of fluorodeoxyglucose-positron emission tomography\/computed tomography in differentiation of malignant mesothelioma from asbestos-related benign pleural disease: an observational pilot study","volume":"4","author":"Yildirim","year":"2009","journal-title":"J\u00a0Thorac Oncol"},{"issue":"8","key":"10.1016\/j.path.2019.10.001_bib39","doi-asserted-by":"crossref","first-page":"e0161764","DOI":"10.1371\/journal.pone.0161764","article-title":"The role of 18F-FDG PET\/CT integrated imaging in distinguishing malignant from benign pleural effusion","volume":"11","author":"Sun","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.path.2019.10.001_bib40","series-title":"WHO classification of tumours of the lung, pleura, thymus and heart","author":"Travis","year":"2015"},{"issue":"1","key":"10.1016\/j.path.2019.10.001_bib41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jss.2015.01.043","article-title":"Impact of mesothelioma histologic subtype on outcomes in the surveillance, epidemiology, and end results database","volume":"196","author":"Meyerhoff","year":"2015","journal-title":"J\u00a0Surg Res"},{"issue":"7","key":"10.1016\/j.path.2019.10.001_bib42","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/modpathol.2012.39","article-title":"Pleomorphic mesothelioma: report of 10 cases","volume":"25","author":"Ord\u00f3\u00f1ez","year":"2012","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.path.2019.10.001_bib43","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/JTO.0b013e318211127a","article-title":"Pleomorphic epithelioid diffuse malignant pleural mesothelioma: a clinicopathological review and conceptual proposal to reclassify as biphasic or sarcomatoid mesothelioma","volume":"6","author":"Kadota","year":"2011","journal-title":"J\u00a0Thorac Oncol"},{"issue":"11","key":"10.1016\/j.path.2019.10.001_bib44","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.5858\/2005-129-1421-DDOBAM","article-title":"Differential diagnosis of benign and malignant mesothelial proliferations on pleural biopsies","volume":"129","author":"Cagle","year":"2005","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"10.1016\/j.path.2019.10.001_bib45","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/00000478-200110000-00012","article-title":"Well-differentiated papillary mesothelioma","volume":"25","author":"Butnor","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.path.2019.10.001_bib46","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/00000478-200404000-00013","article-title":"Well-differentiated papillary mesothelioma of the pleura: a series of 24 cases","volume":"28","author":"Galateau-Sall\u00e9","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2019.10.001_bib47","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41379-018-0127-2","article-title":"Well-differentiated papillary mesothelioma of the peritoneum is genetically defined by mutually exclusive mutations in TRAF7 and CDC42","volume":"32","author":"Stevers","year":"2019","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.path.2019.10.001_bib48","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/modpathol.2008.125","article-title":"Malignant mesothelioma with heterologous elements: clinicopathological correlation of 27 cases and literature review","volume":"21","author":"Klebe","year":"2008","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.path.2019.10.001_bib49","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/PAS.0b013e31802baad7","article-title":"Lymphohistiocytoid variant of malignant mesothelioma of the pleura: a series of 22 cases","volume":"31","author":"Galateau-Sall\u00e9","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.path.2019.10.001_bib50","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jtho.2018.04.023","article-title":"New insights on diagnostic reproducibility of biphasic mesotheliomas: a multi-institutional evaluation by the International Mesothelioma Panel from the MESOPATH reference center","volume":"13","author":"Galateau Salle","year":"2018","journal-title":"J\u00a0Thorac Oncol"},{"issue":"11","key":"10.1016\/j.path.2019.10.001_bib51","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.jtho.2018.07.002","article-title":"Pathologic grading of malignant pleural mesothelioma: an evidence-based proposal","volume":"13","author":"Pelosi","year":"2018","journal-title":"J\u00a0Thorac Oncol"},{"issue":"2","key":"10.1016\/j.path.2019.10.001_bib52","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/modpathol.2011.146","article-title":"A\u00a0nuclear grading system is a strong predictor of survival in epithelioid diffuse malignant pleural mesothelioma","volume":"25","author":"Kadota","year":"2012","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.path.2019.10.001_bib53","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/modpathol.2017.170","article-title":"Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: a multi-institutional study","volume":"31","author":"Rosen","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2019.10.001_bib54","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.lungcan.2018.11.032","article-title":"Molecular pathways and diagnosis in malignant mesothelioma: a review of the 14th International Conference of the International Mesothelioma Interest Group","volume":"127","author":"Chapel","year":"2019","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.path.2019.10.001_bib55","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jtho.2015.11.005","article-title":"The 2015 World Health Organization classification of tumors of the pleura: advances since the 2004 classification","volume":"11","author":"Galateau-Salle","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"issue":"4","key":"10.1016\/j.path.2019.10.001_bib56","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/PAT.0b013e32834642da","article-title":"Validation of a minimal panel of antibodies for the diagnosis of malignant pleural mesothelioma","volume":"43","author":"Kao","year":"2011","journal-title":"Pathology"},{"issue":"5","key":"10.1016\/j.path.2019.10.001_bib57","first-page":"559","article-title":"Expression of thrombomodulin, calretinin, cytokeratin 5\/6, D2-40 and WT-1 in a series of primary carcinomas of the lung: an immunohistochemical study in comparison with epithelioid pleural mesothelioma","volume":"100","author":"Comin","year":"2014","journal-title":"Tumori"},{"issue":"2","key":"10.1016\/j.path.2019.10.001_bib58","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/00000478-200302000-00002","article-title":"Expression of calretinin, thrombomodulin, keratin 5, and mesothelin in lung carcinomas of different types: an immunohistochemical analysis of 596 tumors in comparison with epithelioid mesotheliomas of the pleura","volume":"27","author":"Miettinen","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2019.10.001_bib59","doi-asserted-by":"crossref","first-page":"45768","DOI":"10.1038\/srep45768","article-title":"HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma","volume":"7","author":"Tsuji","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.path.2019.10.001_bib60","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the International Mesothelioma Interest Group","volume":"142","author":"Husain","year":"2018","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1016\/j.path.2019.10.001_bib61","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/modpathol.3800534","article-title":"Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity","volume":"19","author":"Yaziji","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2019.10.001_bib62","doi-asserted-by":"crossref","DOI":"10.1177\/1753466618808660","article-title":"Biomarkers in the diagnosis of pleural diseases: a 2018 update","volume":"12","author":"Porcel","year":"2018","journal-title":"Ther Adv Respir Dis"},{"issue":"2","key":"10.1016\/j.path.2019.10.001_bib63","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1440-1827.2007.02193.x","article-title":"Differential diagnosis of sarcomatoid mesothelioma from true sarcoma and sarcomatoid carcinoma using immunohistochemistry","volume":"58","author":"Kushitani","year":"2008","journal-title":"Pathol Int"},{"issue":"11","key":"10.1016\/j.path.2019.10.001_bib64","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.humpath.2015.06.024","article-title":"BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma","volume":"46","author":"McGregor","year":"2015","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/j.path.2019.10.001_bib65","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/PAS.0000000000000616","article-title":"BAP1 immunohistochemistry and p16 FISH in the diagnosis of sarcomatous and desmoplastic mesotheliomas","volume":"40","author":"Hwang","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.path.2019.10.001_bib66","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/PAS.0000000000000976","article-title":"Loss of BAP1 expression in atypical mesothelial proliferations helps to predict malignant mesothelioma","volume":"42","author":"Pillappa","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.path.2019.10.001_bib67","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/PAS.0000000000000394","article-title":"BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations","volume":"39","author":"Sheffield","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.path.2019.10.001_bib68","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00428-008-0689-3","article-title":"Prognostic significance of p16\/cdkn2a loss in pleural malignant mesotheliomas","volume":"453","author":"Dacic","year":"2008","journal-title":"Virchows Arch"},{"issue":"1","key":"10.1016\/j.path.2019.10.001_bib69","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.lungcan.2008.02.013","article-title":"Frequent p16 inactivation by homozygous deletion or methylation is associated with a poor prognosis in Japanese patients with pleural mesothelioma","volume":"62","author":"Kobayashi","year":"2008","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.path.2019.10.001_bib70","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/modpathol.2015.121","article-title":"The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma","volume":"29","author":"Singhi","year":"2016","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.path.2019.10.001_bib71","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/his.13392","article-title":"The epithelioid bap1-negative and p16-positive phenotype predicts prolonged survival in pleural mesothelioma","volume":"72","author":"Chou","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2019.10.001_bib72","article-title":"MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma","author":"Chapel","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2019.10.001_bib73","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.lungcan.2016.12.017","article-title":"Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: comparison with 9p21 FISH and BAP1 immunohistochemistry","volume":"104","author":"Hida","year":"2017","journal-title":"Lung Cancer"},{"issue":"12","key":"10.1016\/j.path.2019.10.001_bib74","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.5858\/arpa.2018-0273-OA","article-title":"Utility of methylthioadenosine phosphorylase compared with BAP1 immunohistochemistry, and CDKN2A and NF2 fluorescence in situ hybridization in separating reactive mesothelial proliferations from epithelioid malignant mesotheliomas","volume":"142","author":"Berg","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.path.2019.10.001_bib75","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.lungcan.2018.09.019","article-title":"A\u00a0combination of MTAP and BAP1 immunohistochemistry is effective for distinguishing sarcomatoid mesothelioma from fibrous pleuritis","volume":"125","author":"Kinoshita","year":"2018","journal-title":"Lung Cancer"},{"issue":"12","key":"10.1016\/j.path.2019.10.001_bib76","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1158\/2159-8290.CD-18-0804","article-title":"Integrative molecular characterization of malignant pleural mesothelioma","volume":"8","author":"Hmeljak","year":"2018","journal-title":"Cancer Discov"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918119300819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918119300819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:40:09Z","timestamp":1761748809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918119300819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1875918119300819"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2019.10.001","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis of Mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2019.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}